Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3.
Eichholz T, Heubach F, Arendt AM, Seitz C, Brecht IB, Ebinger M, Flaadt T, Süsskind D, Richter L, Hülsenbeck I, Zerweck L, Göricke S, Paulsen F, Dombrowski F, Flotho C, Schönberger S, Ketteler P, Schulte J, Lang P.
Eichholz T, et al. Among authors: zerweck l.
Cancer Immunol Immunother. 2024 Jan 19;73(1):19. doi: 10.1007/s00262-023-03587-0.
Cancer Immunol Immunother. 2024.
PMID: 38240863
Free PMC article.